Adenosine A1 receptors mediate local anti-nociceptive effects of acupuncture

This pioneering study published in Nature Neuroscience in 2010 unraveled the fundamental biological mechanism of acupuncture's analgesic effects, an age-old practice that had until then lacked a solid scientific explanation. Researchers at the University of Rochester, led by Maiken Nedergaard, used sophisticated experimental models in mice to investigate how acupuncture produces pain relief at the molecular level. The methodology involved creating two chronic pain models: inflammatory pain induced by complete Freund's adjuvant (CFA) and neuropathic pain by sciatic nerve ligation. The investigators applied traditional acupuncture at the Zusanli (ST-36) point, inserting needles to a depth of 1.5 mm and performing manual rotation every 5 minutes for 30 minutes.

To monitor biochemical changes, they used microdialysis to collect samples of interstitial fluid near the acupuncture point, analyzing purine levels by high-performance liquid chromatography (HPLC). The results revealed that acupuncture causes a dramatic 24-fold increase in extracellular adenosine concentration, a neuromodulator with well-established anti-nociceptive properties. This increase occurs through ATP release during needle manipulation, followed by its rapid enzymatic degradation to adenosine. Crucially, the study demonstrated that acupuncture's analgesic effects depend entirely on adenosine A1 receptor expression, as genetically modified mice without these receptors showed no pain relief after treatment.

Direct administration of the A1 agonist CCPA completely replicated the effects of acupuncture, confirming that activation of these receptors is both necessary and sufficient for the analgesic effect. The investigators used electrophysiological recordings from the anterior cingulate cortex to demonstrate that adenosine acts locally, suppressing pain signal transmission in unmyelinated C fibers near the acupuncture point. The most notable innovation of the study was the discovery that acupuncture's effects can be potentiated pharmacologically. The investigators identified AMP deaminase as a bottleneck in adenosine metabolism, diverting AMP to IMP rather than adenosine.

Using pentostatin (deoxycoformycin), an FDA-approved deaminase inhibitor, they significantly prolonged acupuncture's analgesic effects from 1-1.5 hours to 3-3.5 hours. This finding opens important clinical prospects for maximizing the therapeutic benefits of acupuncture. The clinical implications are substantial, as the study provides the first robust mechanistic explanation for acupuncture's local and ipsilateral effects, reconciling this traditional practice with evidence-based medicine. The work suggests that drugs that interfere with adenosine metabolism may be used as adjuvants to prolong the clinical effects of acupuncture.

Limitations include the exclusive use of murine models, the need for validation in humans, and questions about generalization to acupuncture points beyond Zusanli. Despite these limitations, this study represents a milestone in the scientific understanding of acupuncture and lays the foundation for the development of more effective therapeutic approaches.